This clinical-stage biopharmaceutical company develops treatments and therapies that target and degrade disease-related proteins using proprietary technology, with drug developments in (immuno)oncology and neurology.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| NGM Biopharmaceuticals Inc NGM | 0 | 358 | 10 November 2020 | |
| Renovaro Inc - RENB - Share chat | 0 | 504 | 18 August 2021 | |
| Verona Pharma plc - $VRNA - Share Chat | 0 | 397 | 7 October 2021 | |
| Cerevel Therapeutics Holdings Inc - CERE - Share Chat | 0 | 641 | 12 March 2021 | |
| Innoviva Inc INVA | 0 | 317 | 10 November 2020 |